Compare Edwards Lifesciences Corporation Common Stock (EW) vs Royal Caribbean Cruises Ltd (RCL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Royal Caribbean Cruises Ltd — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.24 (market cap $48.56B), while Royal Caribbean Cruises Ltd trades at $284.49 (market cap $75.26B). The key difference: Royal Caribbean Cruises Ltd is the larger of the two by market cap, and Royal Caribbean Cruises Ltd pays a 2.13% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | RCL | |
|---|---|---|
Market Cap | $48.56B | $75.26B |
Volume | 6,520,488 | 1,958,628 |
Sector | Health | Consumer Cyclical |
52-Week High | $95.18 | $348.03 |
52-Week Low | $72.65 | $230.30 |
Enterprise Value | $45.01B | $97.91B |
Typical Hold Time | — | 85 Days |
Dividend Yield | — | 2.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Royal Caribbean (RCL) trades at $282.36, down 2.25% today but maintains strong fundamentals with robust revenue growth from $8.8B in 2022 to $17.9B in 2025 and net income surging to $4.27B. The technical picture is bullish with support at $280 and resistance at $287, while analyst consensus favors Buy ratings (51%) with a $346.67 price target. Recent news highlights the $3B Sandals Resorts stake expansion and positive industry momentum from Carnival's strong results.
RCL presents a compelling growth story with expanding margins and strategic diversification, though elevated debt levels and fuel cost sensitivity pose risks. The stock's current valuation at 17.44x P/E offers room for upside relative to analyst targets, supported by consistent earnings beats and bullish institutional sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Royal Caribbean Cruises Ltd
Royal Caribbean is the world's second-largest cruise company, operating 64 ships across five global and partner brands in the cruise vacation industry, with 10 more ships on order. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises, allowing it to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in the first quarter of 2021.
Read more on RCL →
